Botanix Pharmaceuticals Limited (BOT.AX)
AUD 0.36
(-4.05%)
AUD 0.36
(-4.05%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -6.55 Million AUD | -0.15% |
| 2023 | -3.04 Million AUD | -216.64% |
| 2022 | 2.61 Million AUD | -61.56% |
| 2021 | 6.79 Million AUD | -9.08% |
| 2020 | 7.47 Million AUD | 59.5% |
| 2019 | 4.68 Million AUD | 150.57% |
| 2018 | -9.26 Million AUD | -153.76% |
| 2017 | -3.65 Million AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | -100.0% |
| 2005 | 864.00 AUD | -99.81% |
| 2004 | 458 Thousand AUD | -50.49% |
| 2003 | 925 Thousand AUD | 150.68% |
| 2002 | 369 Thousand AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | -100.0% |
| 1997 | 40.52 Million AUD | -1.94% |
| 1996 | 41.32 Million AUD | -37.99% |
| 1995 | 66.64 Million AUD | 48.01% |
| 1994 | 45.02 Million AUD | 36.1% |
| 1993 | 33.08 Million AUD | 23.34% |
| 1992 | 26.82 Million AUD | 5.13% |
| 1991 | 25.51 Million AUD | 21.5% |
| 1990 | 21 Million AUD | 10.53% |
| 1989 | 19 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | -982.43 Thousand AUD | 0.0% |
| 2024 FY | -6.11 Million AUD | -100.88% |
| 2024 Q2 | -3.02 Million AUD | 0.0% |
| 2023 Q2 | -860.07 Thousand AUD | 0.0% |
| 2023 FY | -3.04 Million AUD | -216.64% |
| 2023 Q4 | -2.18 Million AUD | 0.0% |
| 2022 Q2 | -71.03 Thousand AUD | 0.0% |
| 2022 FY | 2.61 Million AUD | -61.56% |
| 2022 Q4 | 2.68 Million AUD | 0.0% |
| 2021 Q4 | -54.21 Thousand AUD | 0.0% |
| 2021 FY | 6.79 Million AUD | -9.08% |
| 2021 Q2 | 6.84 Million AUD | 0.0% |
| 2020 Q2 | 7.53 Million AUD | 0.0% |
| 2020 Q4 | -67.19 Thousand AUD | 0.0% |
| 2020 FY | 7.47 Million AUD | 59.5% |
| 2019 Q4 | -8.96 Million AUD | 0.0% |
| 2019 FY | 4.68 Million AUD | 150.57% |
| 2019 Q2 | -2.98 Million AUD | 0.0% |
| 2018 FY | -9.26 Million AUD | -153.76% |
| 2018 Q2 | -1.55 Million AUD | 0.0% |
| 2018 Q4 | -7.71 Million AUD | 0.0% |
| 2017 Q4 | -2.88 Million AUD | 0.0% |
| 2017 Q2 | -767.17 Thousand AUD | 0.0% |
| 2017 FY | -3.65 Million AUD | 0.0% |
| 2016 Q1 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q3 | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 Q3 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2015 Q1 | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 Q3 | - AUD | 0.0% |
| 2014 Q1 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q1 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q3 | - AUD | 0.0% |
| 2011 Q2 | - AUD | 0.0% |
| 2011 Q1 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2010 Q1 | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q1 | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 Q3 | - AUD | 0.0% |
| 2009 Q2 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2008 Q3 | - AUD | 0.0% |
| 2008 Q2 | - AUD | 0.0% |
| 2008 Q1 | - AUD | 0.0% |
| 2007 Q3 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 Q2 | - AUD | 0.0% |
| 2007 Q1 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2006 FY | - AUD | -100.0% |
| 2006 Q3 | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2006 Q2 | - AUD | -100.0% |
| 2006 Q1 | 216.00 AUD | 0.0% |
| 2005 Q2 | 216.00 AUD | -99.81% |
| 2005 FY | 864.00 AUD | -99.81% |
| 2005 Q1 | 114.37 Thousand AUD | 0.0% |
| 2005 Q4 | - AUD | -100.0% |
| 2005 Q3 | 216.00 AUD | 0.0% |
| 2004 Q4 | - AUD | -100.0% |
| 2004 Q2 | 114.37 Thousand AUD | -50.56% |
| 2004 Q1 | 231.34 Thousand AUD | 0.0% |
| 2004 FY | 458 Thousand AUD | -50.49% |
| 2004 Q3 | 114.37 Thousand AUD | 0.0% |
| 2003 FY | 925 Thousand AUD | 150.68% |
| 2003 Q3 | 231.34 Thousand AUD | 0.0% |
| 2003 Q1 | 92.34 Thousand AUD | 0.0% |
| 2003 Q4 | - AUD | -100.0% |
| 2003 Q2 | 231.34 Thousand AUD | 150.52% |
| 2002 Q2 | 92.34 Thousand AUD | 0.0% |
| 2002 Q4 | - AUD | -100.0% |
| 2002 FY | 369 Thousand AUD | 0.0% |
| 2002 Q3 | 92.34 Thousand AUD | 0.0% |
| 2002 Q1 | - AUD | 0.0% |
| 2001 Q3 | - AUD | 0.0% |
| 2001 Q2 | - AUD | 0.0% |
| 2001 Q4 | - AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1998 FY | - AUD | -100.0% |
| 1998 Q1 | 10.13 Million AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 Q2 | - AUD | -100.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1997 Q4 | - AUD | -100.0% |
| 1997 FY | 40.52 Million AUD | -1.94% |
| 1997 Q1 | 10.33 Million AUD | 0.0% |
| 1997 Q2 | 10.13 Million AUD | -1.94% |
| 1997 Q3 | 10.13 Million AUD | 0.0% |
| 1996 Q2 | 10.33 Million AUD | -37.99% |
| 1996 Q4 | 10.33 Million AUD | 0.0% |
| 1996 FY | 41.32 Million AUD | -37.99% |
| 1996 Q1 | 16.66 Million AUD | 0.0% |
| 1996 Q3 | 10.33 Million AUD | 0.0% |
| 1995 FY | 66.64 Million AUD | 48.01% |
| 1995 Q1 | 11.25 Million AUD | 0.0% |
| 1995 Q4 | 16.66 Million AUD | 0.0% |
| 1995 Q3 | 16.66 Million AUD | 0.0% |
| 1995 Q2 | 16.66 Million AUD | 48.01% |
| 1994 Q2 | 11.25 Million AUD | 36.1% |
| 1994 FY | 45.02 Million AUD | 36.1% |
| 1994 Q4 | 11.25 Million AUD | 0.0% |
| 1994 Q3 | 11.25 Million AUD | 0.0% |
| 1994 Q1 | 8.27 Million AUD | 0.0% |
| 1993 Q1 | 6.7 Million AUD | 0.0% |
| 1993 FY | 33.08 Million AUD | 23.34% |
| 1993 Q4 | 8.27 Million AUD | 0.0% |
| 1993 Q3 | 8.27 Million AUD | 0.0% |
| 1993 Q2 | 8.27 Million AUD | 23.34% |
| 1992 Q2 | 6.7 Million AUD | 5.13% |
| 1992 Q1 | 6.37 Million AUD | 0.0% |
| 1992 Q3 | 6.7 Million AUD | 0.0% |
| 1992 FY | 26.82 Million AUD | 5.13% |
| 1992 Q4 | 6.7 Million AUD | 0.0% |
| 1991 Q4 | 6.37 Million AUD | 0.0% |
| 1991 FY | 25.51 Million AUD | 21.5% |
| 1991 Q1 | 5.25 Million AUD | 0.0% |
| 1991 Q2 | 6.37 Million AUD | 21.5% |
| 1991 Q3 | 6.37 Million AUD | 0.0% |
| 1990 Q1 | 4.75 Million AUD | 0.0% |
| 1990 Q2 | 5.25 Million AUD | 10.53% |
| 1990 FY | 21 Million AUD | 10.53% |
| 1990 Q3 | 5.25 Million AUD | 0.0% |
| 1990 Q4 | 5.25 Million AUD | 0.0% |
| 1989 Q3 | 4.75 Million AUD | 0.0% |
| 1989 FY | 19 Million AUD | 0.0% |
| 1989 Q4 | 4.75 Million AUD | 0.0% |
| 1989 Q2 | 4.75 Million AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AdAlta Limited | 1.5 Million AUD | 534.477% |
| Acrux Limited | -1.28 Million AUD | -410.244% |
| Actinogen Medical Limited | 9.93 Million AUD | 165.967% |
| AnteoTech Limited | 460.39 Thousand AUD | 1523.019% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 352.182% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | -25118.596% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | -774.81% |
| Alterity Therapeutics Limited | 3.8 Million AUD | 272.183% |
| Amplia Therapeutics Limited | 4.01 Million AUD | 263.349% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | -14859.559% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | -2073.349% |
| Biome Australia Limited | 7.66 Million AUD | 185.421% |
| Biotron Limited | -40.49 Thousand AUD | -16077.438% |
| BTC Health Limited | 16.36 Thousand AUD | 40146.082% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 187.896% |
| CSL Limited | 15.28 Billion AUD | 100.043% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 156.937% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 108.389% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 382.925% |
| Dimerix Limited | 583.47 Thousand AUD | 1222.843% |
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 112.86% |
| Hexima Limited | - AUD | Infinity% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 623.464% |
| Immuron Limited | 3.33 Million AUD | 296.342% |
| Immutep Limited | 1.44 Million AUD | 553.738% |
| Imugene Limited | -5.83 Million AUD | -12.187% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 640.442% |
| Memphasys Limited | 1606.00 AUD | 408041.407% |
| Nanollose Limited | -348.95 Thousand AUD | -1777.49% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 103.193% |
| Noxopharm Limited | -534.81 Thousand AUD | -1125.019% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | -7072.93% |
| Nyrada Inc. | -5164.07 AUD | -126767.742% |
| Orthocell Limited | 3.68 Million AUD | 277.624% |
| PharmAust Limited | -1641.00 AUD | -399140.646% |
| Patrys Limited | 1.39 Million AUD | 569.926% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | 11631.963% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | -483.298% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 276.479% |
| PYC Therapeutics Limited | 22.05 Million AUD | 129.7% |
| Race Oncology Limited | 1.38 Million AUD | 571.363% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 69.253% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | -1686.29% |
| Starpharma Holdings Limited | 7.65 Million AUD | 185.563% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 102.124% |
| Tissue Repair Ltd | 150.51 Thousand AUD | 4452.864% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | 63806.136% |